Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
Deciphering the iron side of stroke: neurodegeneration at the crossroads between iron dyshomeostasis, excitotoxicity, and Ferroptosis
The design integrates several key components, as outlined below: the chosen CBBBP is Tat, identified through prior animal experimentation from two candidate peptides for its superior efficacy in facilitating the transport of therapeutic agents crossing BBB
FDA approval normally follows a formal application supported by adequate evidence for a defined product, dose, route, patient population, manufacturing process, labeling, effectiveness, and safety profile
H., and Kim, G
US$ 23.15
US$ 27.71
US$ 22.68
US$ 21.87
